FARN vs. ONT, ERGO, SLN, PRTC, OXB, HZD, VRP, ARIX, BVXP, and 4BB
Should you be buying Faron Pharmaceuticals Oy stock or one of its competitors? The main competitors of Faron Pharmaceuticals Oy include Oxford Nanopore Technologies (ONT), Ergomed (ERGO), Silence Therapeutics (SLN), PureTech Health (PRTC), Oxford Biomedica (OXB), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), Bioventix (BVXP), and 4basebio (4BB). These companies are all part of the "biotechnology" industry.
Faron Pharmaceuticals Oy vs.
Oxford Nanopore Technologies (LON:ONT) and Faron Pharmaceuticals Oy (LON:FARN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, community ranking, earnings, dividends, analyst recommendations, valuation and profitability.
Oxford Nanopore Technologies currently has a consensus target price of GBX 233.33, suggesting a potential upside of 87.65%. Given Oxford Nanopore Technologies' stronger consensus rating and higher probable upside, research analysts clearly believe Oxford Nanopore Technologies is more favorable than Faron Pharmaceuticals Oy.
Faron Pharmaceuticals Oy received 283 more outperform votes than Oxford Nanopore Technologies when rated by MarketBeat users. However, 100.00% of users gave Oxford Nanopore Technologies an outperform vote while only 77.51% of users gave Faron Pharmaceuticals Oy an outperform vote.
Oxford Nanopore Technologies has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500. Comparatively, Faron Pharmaceuticals Oy has a beta of 0.36, suggesting that its stock price is 64% less volatile than the S&P 500.
Faron Pharmaceuticals Oy has a net margin of 0.00% compared to Oxford Nanopore Technologies' net margin of -94.82%. Faron Pharmaceuticals Oy's return on equity of 0.46% beat Oxford Nanopore Technologies' return on equity.
Faron Pharmaceuticals Oy has lower revenue, but higher earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than Faron Pharmaceuticals Oy, indicating that it is currently the more affordable of the two stocks.
In the previous week, Oxford Nanopore Technologies had 1 more articles in the media than Faron Pharmaceuticals Oy. MarketBeat recorded 4 mentions for Oxford Nanopore Technologies and 3 mentions for Faron Pharmaceuticals Oy. Oxford Nanopore Technologies' average media sentiment score of 1.30 beat Faron Pharmaceuticals Oy's score of 0.70 indicating that Oxford Nanopore Technologies is being referred to more favorably in the media.
38.4% of Oxford Nanopore Technologies shares are held by institutional investors. Comparatively, 10.7% of Faron Pharmaceuticals Oy shares are held by institutional investors. 32.6% of Oxford Nanopore Technologies shares are held by company insiders. Comparatively, 31.8% of Faron Pharmaceuticals Oy shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
Oxford Nanopore Technologies beats Faron Pharmaceuticals Oy on 12 of the 17 factors compared between the two stocks.
Get Faron Pharmaceuticals Oy News Delivered to You Automatically
Sign up to receive the latest news and ratings for FARN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Faron Pharmaceuticals Oy Competitors List
Related Companies and Tools
This page (LON:FARN) was last updated on 5/22/2025 by MarketBeat.com Staff
